The effect of Triheptanoin in adults with McArdle Disease (Glycogen Storage Disease Type V)

Trial Profile

The effect of Triheptanoin in adults with McArdle Disease (Glycogen Storage Disease Type V)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Sep 2017

At a glance

  • Drugs Triheptanoin (Primary)
  • Indications Glycogen storage disease type V
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2017 Planned End Date changed from 1 Jul 2017 to 1 Jan 2019.
    • 31 Aug 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Sep 2018.
    • 03 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top